UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
ViroMed confirms VM202’s pain control in animal test
ViroMed said it has confirmed that VM202, an investigational gene therapy b...
by Nam Doo-hyun
|
2018-04-18 11:39
라인
‘Genexine’s pipelines worth more than ₩3 trillion’
Biotech firm Genexine’s major pipelines could be worth more than 3 trillion...
by Nam Doo-hyun
|
2018-04-16 15:48
라인
Obesity drug Saxenda’s sheds ‘1-year effect’ stigma
The government has changed its approval for the efficacy and safety of Saxe...
by Nam Doo-hyun
|
2018-04-11 14:11
라인
CG Bio wins nod for 3D printed artificial cheekbones
CG Bio said it has won a nod from the Ministry of Food and Drug Safety to m...
by Nam Doo-hyun
|
2018-04-10 15:12
라인
Boehringer Ingelheim Korea CEO was forced to resign?
Rumors are circulating in the pharmaceutical industry that Park Ki-hwan, CE...
by Nam Doo-hyun
|
2018-04-06 16:10
라인
Pharmaceutical exports jumped 30% in first two months
South Korea’s exports of pharmaceutical products expanded 30 percent in Jan...
by Nam Doo-hyun
|
2018-04-05 15:09
라인
Invossa’s encouraging trial results presented in US
Invossa, gene therapy for osteoarthritis of the knee, has shown promising r...
by Nam Doo-hyun
|
2018-03-28 15:05
라인
Prescriptions of anticancer drugs surged in January
Prescriptions of anticancer drugs surged in January compared to a year earl...
by Nam Doo-hyun
|
2018-03-27 14:14
라인
Opdivo adds gastric cancer to indications
Bristol-Myers Squibb Korea Pharmaceutical and Ono Pharma Korea said their c...
by Nam Doo-hyun
|
2018-03-27 11:34
라인
Stem cell therapy developers unaffected by Cha Biotech debacle
Shares of biotech firms specializing in stem cell therapies are performing ...
by Nam Doo-hyun
|
2018-03-26 15:58
라인
4 drugmakers’ profits turn to losses
Among KOSDAQ-listed pharmaceutical companies, four firms’ operating profits...
by Nam Doo-hyun
|
2018-03-21 11:38
라인
Foreigners buy SillaJen, Samsung BioLogics, dump Celltrion
Foreign investors net purchased shares of SillaJen and Samsung BioLogics, a...
by Nam Doo-hyun
|
2018-03-20 12:01
라인
‘BMS’ Opdivo to lead cancer immunotherapy market’
Cancer immunotherapy Opdivo has become a new growth engine for Bristol-Myer...
by Nam Doo-hyun
|
2018-03-14 15:16
라인
‘Demand for healthcare cloud service rising’
Cloud service providers that help hospitals manage electronic medical recor...
by Nam Doo-hyun
|
2018-03-12 15:03
라인
‘Me Too’ movement spreads to pharma sector
Amid the nationwide spread of “Me Too” movement, a former employee of Janss...
by Nam Doo-hyun
|
2018-03-08 11:48
라인
Will Invossa face rival cell gene therapy?
The pharmaceutical industry is paying keen attention whether Jointstem, a s...
by Nam Doo-hyun
|
2018-03-07 15:00
라인
‘Order receipt to bolster Samsung BioLogics’ sales’
Samsung BioLogics, which enjoyed more than 50 percent revenue growth in the...
by Nam Doo-hyun
|
2018-03-06 15:58
라인
Researchers find diagnostic biomarker for type 2 diabetes
Korean researchers have found a diagnostic biomarker for type 2 diabetes by...
by Nam Doo-hyun
|
2018-03-05 12:16
라인
Seoul spent ₩2 trillion for new drug development in 7 years
The Korean government has invested a total of 1.96 trillion won ($1.8 billi...
by Nam Doo-hyun
|
2018-03-02 11:59
라인
‘Korea needs genome data standardization'
Korea should standardize genome data to cope with the growing demand for ge...
by Nam Doo-hyun
|
2018-02-28 11:31
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top